Arab Banking Corporation (Jordan) (ASE:ABCO)

Ligand Pharmaceuticals Balance Sheet

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	270.46	224.05	203.36	135.41	77.23	109.69
Investment Securities	254.44	69.15	64.52	293.32	298.93	269.76
Trading Asset Securities	-	0.13	0.38	0.47	0.02	0.09
Mortgage-Backed Securities	32	217	259.95	-	51.93	62.63
Total Investments	286.44	286.28	324.85	293.78	350.88	332.47
Gross Loans	902.96	866.32	854.49	856.68	780.56	720.73
Allowance for Loan Losses	-72.2	-73.33	-67.58	-68.13	-61.1	-55.91
Other Adjustments to Gross Loans	-28.92	-26.34	-23.74	-22.35	-17.34	-14.15
Net Loans	801.84	766.65	763.17	766.2	702.12	650.67
Property, Plant & Equipment	34.32	35.57	32.04	35.7	35.52	31.91
Other Intangible Assets	1	1.13	1.08	1.25	1.56	1.52
Accrued Interest Receivable	8.13	7.24	6.74	8.97	5.83	7.07
Other Receivables	0.06	0.11	0.05	0.09	0.12	0.52
Restricted Cash	36.34	38.69	40.06	40.99	35.26	32.5
Other Current Assets	2.57	1.74	2.6	2.46	2.5	2.31
Long-Term Deferred Tax Assets	5.78	7.78	8.05	8.07	9.07	9.23
Other Real Estate Owned & Foreclosed	9.3	9.69	6.64	6.86	7.09	2.45
Other Long-Term Assets	3.77	4.09	7.3	51.02	2.85	3.26
Total Assets	1,460	1,383	1,396	1,351	1,230	1,184
Accounts Payable	9.33	7.23	5.83	7.21	7.47	9.57
Accrued Expenses	2.34	2.45	1.68	1.88	2.4	1.18
Interest Bearing Deposits	1,009	955.21	938.72	857.01	777.23	759.22
Non-Interest Bearing Deposits	103.2	84.06	106.73	123.6	89.52	82.23
Total Deposits	1,112	1,039	1,045	980.61	866.75	841.45
Short-Term Borrowings	0.29	0.05	2.58	9.42	8.04	3.56
Current Portion of Long-Term Debt	-	65.84	18.9	31.4	42.15	70.68
Current Portion of Leases	-	0	-	0.17	0.16	0.16
Current Income Taxes Payable	0.18	0.36	2.98	2.28	7.26	6.46
Accrued Interest Payable	10.94	12.53	12.12	7.54	5.47	4.38
Other Current Liabilities	3.38	53.45	46.82	43.3	46.32	45.34
Long-Term Debt	91.57	28.69	81.53	84.14	53.58	19.62
Long-Term Leases	2.73	2.77	2.83	2.65	2.6	2.59
Long-Term Unearned Revenue	0.47	0.53	0.47	0.49	0.11	0.13
Other Long-Term Liabilities	57.71	5.18	8.98	15.47	17.03	15.53
Total Liabilities	1,292	1,219	1,231	1,187	1,062	1,024
Common Stock	110	110	110	110	110	110
Additional Paid-In Capital	0.07	0.07	0.07	0.07	0.07	0.07
Retained Earnings	57.63	53.95	55.39	54.79	54.72	45.1
Comprehensive Income & Other	0.36	0.3	-0.12	-1.08	3.57	4.71
Shareholders' Equity	168.05	164.32	165.33	163.77	168.35	159.88
Total Liabilities & Equity	1,460	1,383	1,396	1,351	1,230	1,184
Total Debt	94.59	97.35	105.85	127.78	106.53	96.61
Net Cash (Debt)	175.87	126.83	115.65	15.63	-5.3	20.51
Net Cash Growth	111.12%	9.66%	639.99%	-	-	-23.45%
Net Cash Per Share	1.60	1.15	1.05	0.14	-0.05	0.19
Filing Date Shares Outstanding	110	110	110	110	110	110
Total Common Shares Outstanding	110	110	110	110	110	110
Book Value Per Share	1.53	1.49	1.50	1.49	1.53	1.45
Tangible Book Value	167.05	163.19	164.25	162.52	166.8	158.36
Tangible Book Value Per Share	1.52	1.48	1.49	1.48	1.52	1.44

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.